Skip to content
Article Rich – Lifestyle
Author:
Pyxis Oncology
Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones
June 30, 2026
Pyxis Oncology to Participate in Upcoming Investor Conferences
May 21, 2026
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
May 7, 2026
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
April 17, 2026
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 23, 2026